Intellectual Property Rights

F. Hoffmann-La Roche & Co. Ltd. v. Geoffrey Manners & Co. Pvt. Ltd.

AIR 1970 SC 2062

Facts

Hoffmann-La Roche owned the trademark PROTOVIT for vitamin preparations.
Geoffrey Manners sought registration of DROPOVIT for medicinal and vitamin products.
Roche opposed registration.
It argued that:
both marks ended with “VIT”;
the products were similar;
the marks were visually and phonetically deceptively similar.
Geoffrey Manners argued that:
the marks should be considered as wholes;
“VIT” was commonly suggestive of vitamins;
the prefixes “PROTO” and “DROPO” created distinct commercial impressions.
The Registrar and the High Court permitted registration.
Roche appealed to the Supreme Court.

Deceptive similarity is determined by the probable effect of the mark on ordinary purchasers.
Intention to deceive is unnecessary.
The court asks whether the mark is likely to:
deceive;
cause confusion;
create mistaken association.
Competing word marks must be compared as wholes.
The court should not:
place them side by side for microscopic inspection;
dissect them into common and uncommon fragments mechanically.
However, where a common element is descriptive or commonly used, greater significance may attach to the distinguishing portions.
Visual appearance, pronunciation, idea and surrounding trade circumstances must all be considered.

The Court acknowledged that both marks contained the suffix VIT.
In relation to vitamin preparations, “VIT” naturally suggested vitamins.
Roche could not claim an unrestricted monopoly over that common element.
The remaining portions were therefore important:
PROTO in PROTOVIT;
DROPO in DROPOVIT.
The marks differed in:
beginning sound;
syllabic structure;
visual appearance;
overall pronunciation.
PROTOVIT would be pronounced with a “proto” beginning.
DROPOVIT began with the clearly different “dropo” sound.
The Court considered the entire words as ordinary purchasers would encounter them.
It rejected a letter-by-letter analysis focusing only on the shared final syllable.
The fact that both goods were vitamin preparations made careful comparison important.
However, similarity of goods does not automatically establish similarity of marks.
The overall marks remained sufficiently distinct.
The Court also considered whether DROPOVIT was descriptive.
Although it might suggest vitamin drops, the word as a whole was not an ordinary dictionary expression directly naming the goods.
It was an invented combination capable of registration.
Roche did not establish a reasonable probability that consumers would mistake one product for the other merely because both marks referred indirectly to vitamins.

The Supreme Court dismissed Roche’s appeal.
It held that PROTOVIT and DROPOVIT, viewed as whole marks, were not deceptively similar.
DROPOVIT was treated as an invented and registrable word.
Use this case for: marks must be compared in their entirety, and a proprietor cannot base confusion solely upon a common descriptive or suggestive element such as “VIT” for vitamins.